Symbols

Boston Scientific Slides to 186th in Trading Activity as Institutional Buyers Pile In Despite Downtick in Volume and Insider Sales

Generated by AI AgentAinvest Volume Radar

Tuesday, Sep 9, 2025 7:37 pm ET1min read

Aime Summary

- Boston Scientific’s stock fell to 186th in trading activity on Sept. 9, 2025, with a 29.51% volume drop and 0.05% price decline.

- Institutional investors increased stakes, including UBS AM’s 18.7% and Vanguard’s 1.3% holdings, signaling confidence.

- Analysts raised price targets to $125, but insiders sold 42.32%–21.90% of holdings in August, raising concerns.

- Q2 2025 revenue of $5.06B exceeded forecasts, with $158.76B market cap and a defensive beta of 0.65.

On September 9, 2025, , . , ranking 186th in trading activity among listed equities.

Recent institutional activity highlights growing confidence in the company. NewEdge Advisors LLC increased its stake by 7.8% in the first quarter, . UBSUBS-- AM boosted holdings by 18.7% in the fourth quarter, . Vanguard Group Inc. , .

Analyst sentiment remains positive despite recent insider sales. , while Raymond James and UBS GroupUBS-- reiterated "Buy" or "Strong Buy" ratings. However, insiders including EVP Arthur C. , , respectively.

, exceeding expectations, . , , reflecting a defensive profile relative to broader markets.

I can definitely help you design and evaluate that strategy, but to run an actual back-test we need to pin down a few practical details: 1. Universe definition 2. Data frequency & execution convention 3. Portfolio construction 4. Performance aggregation. Once those points are clarified I can generate the signal file and run the back-test for the 2022-01-01 → present window.

Ainvest Volume Radar

Hunt down the stocks with explosive trading volume.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments

﻿

Add a public comment...

No comments yet

AInvest
PRO

Editorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process. While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context. Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Boston Scientific Slides to 186th in Trading Activity as Institutional Buyers Pile In Despite Downtick in Volume and Insider Sales

Latest Articles

Stay ahead of the market.

Comments

AInvestPRO

AInvest

AInvest
PRO